Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?

Shahirose Jessani1, Teri Millane, Gregory Y H Lip

  • 1University Department of Medicine, City Hospital, Birmingham B18 7QH, England, UK.

Insights

Impaired glucose tolerance (IGT) significantly increases cardiovascular risk and mortality, even before overt diabetes develops. Understanding vascular damage mechanisms in IGT is crucial for early intervention and improved patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Impaired glucose tolerance (IGT) is a significant, independent predictor of cardiovascular morbidity, mortality, and overall mortality.
  • Individuals with IGT post-myocardial infarction exhibit increased major adverse cardiac events and reduced survival rates.
  • The pathophysiological link between IGT and cardiovascular disease (CVD) requires further elucidation.

Purpose of the Study:

  • To review the pathophysiological basis of IGT.
  • To explore the mechanisms of vascular damage in IGT.
  • To understand IGT's impact on cardiovascular disease (CVD).

Main Methods:

  • Literature review focusing on pathophysiological mechanisms of vascular damage in IGT.
  • Analysis of endothelial damage, aberrant angiogenesis, and apoptosis in the context of IGT.
  • Evaluation of post-prandial or post-challenge hyperglycemia effects.

Main Results:

  • IGT contributes to vascular complications through endothelial damage, aberrant angiogenesis, and apoptosis.
  • These mechanisms are active in IGT, preceding the development of overt diabetes mellitus.
  • Understanding these pathways in IGT offers insights into long-term cardiovascular complications.

Conclusions:

  • IGT is a critical risk factor for cardiovascular events and mortality.
  • Endothelial dysfunction, angiogenesis abnormalities, and apoptosis are key mechanisms of vascular damage in IGT.
  • Further research into IGT's vascular impact can guide therapeutic strategies.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...